Press releases

Burgdorf-based medical technology supplier Ypsomed, the leading independent developer and manufacturer of custom-made injection pens for pharmaceutical and biotech companies, and one of the leading suppliers of pen needles, is currently assessing a range of options to finance its rapid growth. The possibility of a listing on the Swiss Stock Exchange (SWX) is also being examined.

Read more... Ypsomed expands further and examines initial public offering